The size of the remote patient monitoring market in the Middle-East and Africa was worth USD 505.05 Million in 2022 and is estimated to be growing at a CAGR of 13.75%, to reach USD 961.81 Million by 2027.
The expansion of the remote patient monitoring market in the Middle East and Africa is being fueled by an increase in the chronic disease population and an aging population, and demand for home-based monitoring equipment. According to research published by the South African Council for Medical Schemes, the burden of chronic diseases in Africa is increasing, with hypertension, hyperlipidemia, and diabetes mellitus 2 being the most common disorders. As a result, the need for remote patient monitoring equipment is rising. In addition, the growing geriatric population and the need to expand healthcare access, the cost benefits of telehealth and remote patient monitoring, the benefits of RPM to reduce the burden on medical resources, advancements in telecommunications, rising chronic disease incidences, and increased investments in telehealth and RPM are driving the market forward.
As the prevalence of chronic diseases rises, caregivers suffer a substantial financial burden. RPM technologies are used to detect minor changes in the patient's physiological data and encourage self-monitoring. As a result, it decreases readmissions and avoids unnecessary hospitalizations. Furthermore, these technologies reduce the number of needless journeys to the doctor's office and the travel-related costs associated with receiving proper medical care. RPM technologies, when properly implemented, can increase access to high-quality healthcare while saving time and money in the short and long term.
Despite factors increasing the adoption of remote patient monitoring systems, the patient monitoring equipment market in the Middle East and Africa faces obstacles such as a lack of adequate reimbursement policies and a demanding regulatory environment. In telehealth and telemedicine, healthcare fraud is a significant concern. A patient or a doctor can be used in several ways. For example, the identity and accounts of a physician can be utilized to earn money from an insurance company, or non-eligible or non-listed institutional providers can make false claims using improper coding and billing. Behavioral barriers to telehealth and telemedicine adoption may not be the most evident stumbling obstacle, but they are substantial. New techniques are often foreign to physicians and patients, who are unwilling to forsake their current (conventional) ways. In addition, older persons may reject telehealth and telemedicine services due to their lack of familiarity with technology.
This research report on the Middle East and Africa Remote Patient Monitoring market has been segmented and sub-segmented into the following categories:
Over 225 people in South Africa die from heart disease or stroke every day. Furthermore, Cardiovascular Disease has been identified as a primary cause of death in the Middle East region. According to the Saudi Heart Association, a heart attack is responsible for one out of every five deaths in the United Arab Emirates (UAE). The Middle East and Africa region have a high incidence of heart disease, which is the primary reason for the rising demand for heart monitors in this region, likely to fuel the market's rise. Outside of a clinical setup, remote patient monitoring technologies can keep track of a patient's health. This monitoring can be done at home or in any location where healthcare is not readily available. The COVID-19 pandemic has resulted in a lack of hospital beds. Aside from that, patients, particularly those with chronic conditions, are recommended to minimize physical trips to hospitals due to the risk of infection. Hospitals have used a remote patient monitoring system to keep track of a patient's health. As a result, amid the COVID-19 pandemic, a remote patient monitoring system is likely to play a critical role in this region.
KEY MARKET PLAYERS:
Companies playing a leading role in the MEA Remote Patient Monitoring Systems Market profiled in the report are Welch Allyn, Bosch, Johnson & Johnson, Intel, Roche, Philips Healthcare, Philips, Healthanywhere Inc, Honeywell, American Telecare, Biotronik, and Covidien Plc.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com